Agios Pharmaceuticals prices IPO at $18, above the range

By
A A A

Agios Pharmaceuticals, a biotech developing metabolic treatments for cancer and rare genetic diseases, raised $106 million by offering 5.9 million shares at $18, above the range of $14 to $16. Agios had originally planned to sell 5.0 million shares. Agios Pharmaceuticals plans to list on the NASDAQ under the symbol AGIO. J.P. Morgan and Goldman Sachs acted as joint bookrunners on the deal.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: AGIO

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

86,627,350
  • $61.80 ▼ 3.33%
58,636,005
  • $15.44 ▼ 1.03%
43,254,709
  • $64.8725 ▼ 0.15%
39,355,269
  • $3.38 ▲ 0.90%
39,064,711
  • $4.29 ▲ 1.42%
38,037,134
  • $95.035 ▼ 0.37%
36,100,193
  • $94.66 ▼ 0.32%
32,857,379
  • $26.20 ▼ 0.46%
As of 7/10/2014, 04:04 PM